Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBXA2R | P21731 | 19/20 | 0.59 |
| ▸ | PTGDR | Q13258 | 19/20 | 0.59 |
| ▸ | PDE2A | O00408 | 3/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6268653 | 1.00 | TBXA2R (0.59) | TBXA2RPTGDRPDE2A | |
| SCHEMBL6270536 | 1.00 | TBXA2R (0.59) | TBXA2RPTGDRPDE2A | |
| SCHEMBL6268649 | 1.00 | TBXA2R (0.59) | TBXA2RPTGDRPDE2A | |
| SCHEMBL347874 | 0.90 | TBXA2R (0.72) | TBXA2RPTGDRPDE2A | |
| SCHEMBL31156664 | 0.90 | TBXA2R (0.72) | TBXA2RPTGDRPDE2A | |
| SCHEMBL17589695 | 0.90 | TBXA2R (0.72) | TBXA2RPTGDRPDE2A | |
| SCHEMBL347602 | 0.90 | TBXA2R (0.72) | TBXA2RPTGDRPDE2A | |
| SCHEMBL7781310 | 0.90 | TBXA2R (0.72) | TBXA2RPTGDRPDE2A | |
| SCHEMBL31018198 | 0.90 | TBXA2R (0.72) | TBXA2RPTGDRPDE2A | |
| SCHEMBL347601 | 0.90 | TBXA2R (0.72) | TBXA2RPTGDRPDE2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20010047027-A1 | Prostaglandin D2 receptor antagonists | LABELLE MARC (US) | 2001-11-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010047027-A1 | Prostaglandin D2 receptor antagonists | PTGDR2, PTGDR, LTB4R2 | TBXA2R 21/4885PTGDR 2/4885PDE2A 1557/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.